Circulatory support for high-risk angioplasty
Part of Heart & circulation clinical trials.
This study tests a device that helps keep blood moving during a high-risk angioplasty (a procedure to open blocked heart arteries). It may help patients who are not good candidates for standard angioplasty alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a planned (not emergency) angioplasty to open a blocked heart artery or bypass graft.
- Your blood count (hemoglobin) is above 10.0 g/dl and you don't have an active bleeding source.
- A team of heart specialists has agreed that high-risk angioplasty is right for you.
- You must be able to sign a consent form and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
This study looks at using a temporary heart pump called Impella ECP during planned high-risk heart stent procedures (PCI). It may help doctors support the heart more safely while placing the stents.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
This study tests whether using a special heart pump (called Impella) during a high-risk procedure to open blocked heart arteries can help protect your heart. It aims to see if this support improves the success and safety of the procedure in people with weak hearts.
This trial tests a new device called the Supira system to support the heart during a high-risk procedure to open blocked arteries. It is for people who are stable enough to wait for the procedure (not in emergency or shock).
This trial tests a new heart pump (Ventiflow LP) that helps support the heart during a procedure to open blocked coronary arteries (angioplasty or PCI) in people whose hearts are weak. It may help those who are too high risk for bypass surgery.
Hear when a new High-Risk Percutaneous Coronary Intervention (High-risk PCI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.